Ligand Pharmaceuticals
LGND
#2813
Rank
โ‚ฌ5.28 B
Marketcap
264,32ย โ‚ฌ
Share price
-2.71%
Change (1 day)
47.84%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): โ‚ฌ51.9 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.25 Billion. In 2025 the company made an earning of โ‚ฌ0.14 Billion, an increase over its 2024 earnings that were of โ‚ฌ5.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ51.9 M-65.13%
2025 โ‚ฌ0.14 B2848.57%
2024 โ‚ฌ5.04 M-91.37%
2023 โ‚ฌ58.49 M-7.59%
2022 โ‚ฌ63.3 M4%
2021 โ‚ฌ60.86 M296.42%
2020 โ‚ฌ15.35 M-97.97%
2019 โ‚ฌ0.75 B275.62%
2018 โ‚ฌ0.20 B237.48%
2017 โ‚ฌ59.72 M49.05%
2016 โ‚ฌ40.06 M55.41%
2015 โ‚ฌ25.78 M36.87%
2014 โ‚ฌ18.83 M29.59%
2013 โ‚ฌ14.53 M1309.35%
2012 โ‚ฌ1.03 M-43.97%
2011 โ‚ฌ1.84 M-113.19%
2010 -โ‚ฌ13.96 Million59.86%
2009 -โ‚ฌ8.74 Million-61.33%
2008 -โ‚ฌ22.58 Million-58.75%
2007 -โ‚ฌ54.73 Million20.52%
2006 -โ‚ฌ45.42 Million81.27%
2005 -โ‚ฌ25.06 Million
2003 -โ‚ฌ17.45 Million-20.6%
2002 -โ‚ฌ21.97 Million4.38%
2001 -โ‚ฌ21.05 Million-48.83%
2000 -โ‚ฌ41.13 Million-19.74%
1999 -โ‚ฌ51.24 Million-19.06%
1998 -โ‚ฌ63.31 Million126.71%
1997 -โ‚ฌ27.93 Million-5.83%
1996 -โ‚ฌ29.65 Million136.23%
1995 -โ‚ฌ12.56 Million-33.97%
1994 -โ‚ฌ19.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.02 B 30,636.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.33 B 11,340.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ31.62 B 56,983.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.05 B 18,045.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.18 Billion-407.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.11 B 10,937.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.30 B 18,504.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ6.50 B 11,646.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ56.29 Million-201.60%๐Ÿ‡บ๐Ÿ‡ธ USA